Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Hormonal Biomarkers of Uterine Cancer Progression in Patients With Abnormal Uterine Bleeding

NCT07581288 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07581288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07581288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Hormonal Biomarkers of Uterine Cancer Progression in Patients With Abnormal Uterine Bleeding
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
September 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, endometrial hyperplasia, endometrial intraepithelial neoplasia, menstrual cycle, reproductive endocrinology, uterine bleeding, uterine cancer, uterine neoplasms